TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NGNE

Neurogene Inc

Healthcare · Biotechnology · —

33.60$ +3.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NGNE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0%
351.0%
100.0% -251.0%
131.2% 6,585.6%
2,444.6%
194.1% 8,679.2%
-94.1% -8,930.3%
0.0% 1.3%
-126.3% -8,123.7%
-126.3% -8,123.7%
-126.3% -7,771.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?